Quest Diagnostics
DGX
#1090
Rank
ยฃ13.59 B
Marketcap
ยฃ121.80
Share price
1.04%
Change (1 day)
13.58%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): ยฃ5.47

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is ยฃ5.38. In 2022 the company made an earnings per share (EPS) of ยฃ6.41 a decrease over its 2021 EPS that were of ยฃ12.63.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ5.47-14.71%
2022ยฃ6.41-49.21%
2021ยฃ12.6349.72%
2020ยฃ8.4366.67%
2019ยฃ5.0618%
2018ยฃ4.29-4.26%
2017ยฃ4.4823.19%
2016ยฃ3.64-7.11%
2015ยฃ3.9128.46%
2014ยฃ3.05-31.61%
2013ยฃ4.4660.46%
2012ยฃ2.78-16.51%
2011ยฃ3.332.45%
2010ยฃ3.254.35%
2009ยฃ3.1130.77%
2008ยฃ2.3868.93%
2007ยฃ1.41-40.6%
2006ยฃ2.379.96%
2005ยฃ2.1610.39%
2004ยฃ1.9516.35%
2003ยฃ1.6826.73%
2002ยฃ1.3290.29%
2001ยฃ0.7053.51%
2000ยฃ0.45-22900%
1999-ยฃ0.001989-101.11%
1998ยฃ0.18-216.88%
1997-ยฃ0.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ยฃ5.98 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.27-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.73-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.75-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.16-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands